Jean-Sébastien Frenel: Can AI Predict Which Ovarian Cancer Patients Benefit From PARP Inhibitors?
Jean-Sebastien Frenel, Professor of Medical Oncology at the University of Nantes, shared a post on LinkedIn: “Can a routine pathology…
Browsing Category